Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update PR Newswire CRANFORD, N.J., Dec. 27, 2024 CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full...